By Nick Johnson (Apyx) In 2025 Shareholder News, RenuvionPosted April 29, 2025APYX MEDICAL CORPORATION ANNOUNCES TWO PEER-REVIEWED PUBLICATIONS ON THE USE OF RENUVION IN ABDOMINAL BODY CONTOURING PROCEDURES READ MORE
By Nick Johnson (Apyx) In 2025 Shareholder News, J-Plasma, RenuvionPosted April 24, 2025APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2025 FINANCIAL RESULTS ON MAY 8, 2025 READ MORE